Cargando…
Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis
Fibrosing diseases are a major medical problem, and are associated with more deaths per year than cancer in the US. Sialidases are enzymes that remove the sugar sialic acid from glycoconjugates. In this review, we describe efforts to inhibit fibrosis by inhibiting sialidases, and describe the follow...
Autores principales: | Karhadkar, Tejas R., Chen, Wensheng, Pilling, Darrell, Gomer, Richard H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820515/ https://www.ncbi.nlm.nih.gov/pubmed/36613682 http://dx.doi.org/10.3390/ijms24010239 |
Ejemplares similares
-
The sialidase NEU3 promotes pulmonary fibrosis in mice
por: Pilling, Darrell, et al.
Publicado: (2022) -
Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model
por: Karhadkar, Tejas R., et al.
Publicado: (2017) -
A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet
por: Pilling, Darrell, et al.
Publicado: (2020) -
Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice
por: Karhadkar, Tejas R., et al.
Publicado: (2021) -
Monocyte differentiation and macrophage priming are regulated differentially by pentraxins and their ligands
por: Pilling, Darrell, et al.
Publicado: (2017)